These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1323695)

  • 21. [Synthesis, immunogenicity and antigenic characteristics of the glycoprotein E fragments from the tick-borne encephalitis virus].
    Volkova TD; Vol'pina OM; Zhmak MN; Ivanov VT; Vorovich MF; Timofeev AV
    Bioorg Khim; 2001; 27(3):174-9. PubMed ID: 11443938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.
    Simpson JA; Chow JC; Baker J; Avdalovic N; Yuan S; Au D; Co MS; Vasquez M; Britt WJ; Coelingh KL
    J Virol; 1993 Jan; 67(1):489-96. PubMed ID: 7677958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL.
    Chirnside ED; de Vries AA; Mumford JA; Rottier PJ
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1989-98. PubMed ID: 7636479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response to neutralizing epitope on human cytomegalovirus gylcoprotein B in Japanese: correlation of serologic response with HLA-type.
    Wada K; Mizuno S; Ohta H; Nishiyama Y
    Microbiol Immunol; 1997; 41(10):841-5. PubMed ID: 9403513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus.
    Qadri I; Navarro D; Paz P; Pereira L
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2913-21. PubMed ID: 1279102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to immunodominant and neutralizing domains of the envelope surface protein of feline immunodeficiency virus.
    Egberink H; Keldermans L; Schuurman N; Stam J; Hesselink W; van Vliet A; Verschoor E; Horzinek M; de Ronde A
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():889-93. PubMed ID: 7512121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein.
    Tarar MR; Emery VC; Harrison TJ
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):183-92. PubMed ID: 9116635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Megret F; Hugnot JP; Falconar A; Gentry MK; Morens DM; Murray JM; Schlesinger JJ; Wright PJ; Young P; Van Regenmortel MH
    Virology; 1992 Apr; 187(2):480-91. PubMed ID: 1372140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of a fusion protein containing the antigenic domain 1 of human cytomegalovirus glycoprotein B and its application in ELISA tests.
    Sousa F; Melo A; Almeida S; Paixão P; Queiroz JA; Domingues FC
    Biotechnol Lett; 2006 Jan; 28(2):73-7. PubMed ID: 16369688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation into the heparin-binding properties of a synthetic peptide deduced from the antigenic domain 2 of human cytomegalovirus glycoprotein B.
    Silvestri ME; Sundqvist VA
    Scand J Immunol; 2001 Mar; 53(3):282-9. PubMed ID: 11251886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine mapping of bovine herpesvirus-1 (BHV-1) glycoprotein D (gD) neutralizing epitopes by type-specific monoclonal antibodies and sequence comparison with BHV-5 gD.
    Abdelmagid OY; Minocha HC; Collins JK; Chowdhury SI
    Virology; 1995 Jan; 206(1):242-53. PubMed ID: 7530392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus.
    Kropff B; Landini MP; Mach M
    J Med Virol; 1993 Mar; 39(3):187-95. PubMed ID: 8385703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional importance of amino acid residues making up peptide antigenic determinants.
    Pinilla C; Appel JR; Houghten RA
    Mol Immunol; 1993 Apr; 30(6):577-85. PubMed ID: 7683750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of major neutralizing epitopes on the S1 polypeptide of the murine coronavirus peplomer glycoprotein.
    Takase-Yoden S; Kikuchi T; Siddell SG; Taguchi F
    Virus Res; 1991 Mar; 18(2-3):99-107. PubMed ID: 1645909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.
    Lantto J; Fletcher JM; Ohlin M
    J Gen Virol; 2002 Aug; 83(Pt 8):2001-2005. PubMed ID: 12124464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response.
    Urban M; Klein M; Britt WJ; Hassfurther E; Mach M
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1537-47. PubMed ID: 8757997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
    Garcia-Valcarcel M; Fowler WJ; Harper DR; Jeffries DJ; Layton GT
    Vaccine; 1997; 15(6-7):709-19. PubMed ID: 9178473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.